Market cap
$1,710 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
4.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | -15.91 | -62.14 | -40.38 | -197.95 | -249.31 |
| Net Profit | -15.91 | -62.14 | -40.38 | -197.91 | -249.37 |
| EPS | -8.45 | -46.32 | -33.92 | -115.78 | -214.40 |
| Book Value | -- | -- | -25.39 | -10.71 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -- | -- | -- | -- | -- |
| Net Margin
| -- | 217,123.69 | -- | -- | -- |
| Return on equity
| -33.78 | -27.60 | -48.48 | -39.83 | -31.60 |
| Return on Capital
| -33.09 | -27.14 | -- | -39.05 | -30.88 |
| Return on Assets
| -31.52 | -25.77 | -39.98 | -37.13 | -29.34 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.02 | 0.02 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Tyra Biosciences (TYRA)
|
--
|
-39.05
|
-30.88
|
-29.34
|
-18.36
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-48.48
Lower than Peers by 8.15
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Tyra Biosciences (TYRA)
|
-48.48
|
-39.83
|
-31.60
|
-29.92
|
-18.49
|
|
Peer Median
|
-40.33
|
--
|
--
|
--
|
--
|
ROA
-39.98
Lower than Peers by 8.73
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Tyra Biosciences (TYRA)
|
-39.98
|
-37.13
|
-29.34
|
-28.10
|
-18.06
|
|
Peer Median
|
-31.24
|
--
|
--
|
--
|
--
|
Net Margin
--
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Tyra Biosciences (TYRA)
|
--
|
--
|
--
|
--
|
-1,435.95
|
|
Peer Median
|
-91.30
|
--
|
--
|
--
|
--
|
EBIT Growth
-40.38
Lower than Peers by 39.36
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Tyra Biosciences (TYRA)
|
-40.38
|
-38.70
|
-25.09
|
-17.32
|
-124.16
|
|
Peer Median
|
-1.02
|
--
|
--
|
--
|
--
|
Net Profit Growth
-40.38
Lower than Peers by 32.84
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Tyra Biosciences (TYRA)
|
-40.38
|
-38.70
|
-25.09
|
-33.66
|
-97.86
|
|
Peer Median
|
-7.53
|
--
|
--
|
--
|
--
|
EPS Growth
-33.92
Lower than Peers by 48.15
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Tyra Biosciences (TYRA)
|
-33.92
|
-0.37
|
0.09
|
-0.31
|
-0.94
|
|
Peer Median
|
14.23
|
--
|
--
|
--
|
--
|
Book Value Growth
5.63
Higher than Peers by 15.76
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Tyra Biosciences (TYRA)
|
5.63
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-10.13
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Tyra Biosciences (TYRA)
|
--
|
0.02
|
0.02
|
0.03
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.00
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Tyra Biosciences (TYRA)
|
0.00
|
0.00
|
0.00
|
0.00
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
14.91
Higher than Peers by 9.10
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Tyra Biosciences (TYRA)
|
14.91
|
14.67
|
23.81
|
13.80
|
45.13
|
|
Peer Median
|
5.81
|
--
|
--
|
--
|
--
|
Quick Ratio
14.91
Higher than Peers by 9.21
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Tyra Biosciences (TYRA)
|
14.91
|
--
|
--
|
--
|
--
|
|
Peer Median
|
5.70
|
--
|
--
|
--
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Tyra Biosciences (TYRA)
|
--
|
--
|
--
|
--
|
-199.08
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Tyra Biosciences (TYRA)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.06
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Tyra Biosciences (TYRA)
|
--
|
591.36
|
1,848.07
|
3,004.26
|
1,076.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Tyra Biosciences (TYRA)
|
--
|
-13.06
|
-9.46
|
-8.61
|
-6.20
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
4.27
Lower than Peers by 1.06
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Tyra Biosciences (TYRA)
|
4.27
|
6.05
|
2.38
|
2.91
|
1.24
|
|
Peer Median
|
5.33
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Tyra Biosciences (TYRA)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-6.95
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Tyra Biosciences (TYRA)
|
-6.95
|
-11.03
|
-5.62
|
-5.79
|
-1.23
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
1,710
Higher than Peers by 1,568
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Tyra Biosciences (TYRA)
|
1,710
|
--
|
--
|
--
|
--
|
|
Peer Median
|
142
|
--
|
--
|
--
|
--
|